Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenglin Yi

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cellular & Molecular Biology Letters|September 5, 2024
Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signalingChunyu Zhang, Jiao Hu, Zhi Liu, et al.
Cancers|November 11, 2022
Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor ImmunotherapyYunbo He, Jinliang Huang, Qiaorong Li, et al.
Frontiers in Immunology|September 16, 2021
N<sup>6</sup>-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic TargetChao Quan, Othmane Belaydi, Jiao Hu, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48Jiatong Xiao, Jinhui Liu, Chunyu Zhang, et al.
Theranostics|February 3, 2025
TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistanceZhi Liu, Chunyu Zhang, Jiatong Xiao, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cellular & Molecular Biology Letters|September 5, 2024
Hsa_circ_0000520 suppresses vasculogenic mimicry formation and metastasis in bladder cancer through Lin28a/PTEN/PI3K signalingChunyu Zhang, Jiao Hu, Zhi Liu, et al.
Cancers|November 11, 2022
Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor ImmunotherapyYunbo He, Jinliang Huang, Qiaorong Li, et al.
Frontiers in Immunology|September 16, 2021
N<sup>6</sup>-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic TargetChao Quan, Othmane Belaydi, Jiao Hu, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Overcoming immunotherapy resistance in bladder cancer with a novel antibody-drug conjugate RC48Jiatong Xiao, Jinhui Liu, Chunyu Zhang, et al.
Theranostics|February 3, 2025
TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistanceZhi Liu, Chunyu Zhang, Jiatong Xiao, et al.
Pageof 3